Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases
Clinical trial NCT05588388 · RECRUITING
Trial details
- NCT number
- NCT05588388
- Sponsor
- Kamya Sankar
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-11
- Primary completion
- 2026-12-28
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.